The Rx Consultant 

Smoking Cessation For the Busy Clinician for Technicians

This CE activity was originally published in The Rx Consultant.  If you received credit for it previously, you cannot receive credit for it again.

More than 50 years after the landmark 1964 Surgeon General’s Report on the health consequences of smoking, an estimated 15% of adult Americans still smoke. Smoking remains the leading cause of preventable death in the United States – accounting for 480,000 deaths per year (1 of every 5). People who quit smoking greatly reduce their risk for tobacco-related diseases, including cancer, heart disease, and lung disease, while also increasing life expectancy and improving quality of life. Each year, the economic costs due to tobacco use, including direct medical care and lost productivity, exceed $289 billion. For each pack of cigarettes sold, the societal costs due to smoking-related health care costs and lost productivity are estimated at $19.16 per pack, nearly 3 times the average cost of a pack of cigarettes ($6.16).

The good news is that 68% of all adults who smoke want to quit. Effective treatments are available—medications, behavioral counseling, or both—with successful quit rates of around 20-37% at least 6 months after quitting. However, most patients attempt to quit unassisted (without using proven cessation treatments). During 2015 only about one third of smokers used behavioral counseling and/or medications to assist them when trying to quit.

Over the past several years, research has guided our clinical approach to treating tobacco use and dependence. When used correctly, the FDA-approved medications for smoking cessation approximately double the likelihood of quitting. Further benefit is seen when medications are combined with behavioral counseling. Although more intensive interventions provide higher quit rates, even brief advice from healthcare providers—as few as 3 minutes—has been shown to have an impact on patients’ likelihood of quitting...



CE Hours


CE Units


Activity Type


Target Audience(s)

This accredited program is targeted to pharmacy technicians.


This CE activity was developed by The Rx Consultant, a publication of Continuing Education Network, Inc.

CE activities for Pharmacists and Pharmacy Technicians:
This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours.  CE credit is automatically reported to CPE Monitor.
CE activities for Nurse Practitioners and Clinical Nurse Specialists: 
    This continuing education activity meets the requirements of:
        The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics.
        The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE.
    This is a pharmacotherapeutics/pharmacology CE activity.
  • The ANCC requires all advanced practice nursing certificants (CNSs and NPs) to complete 25 CE hours of pharmacotherapeutics as a portion of the required 75 continuing education hours.
  • Pharmacology CE is recommended by the AANPCP and will be required for Certificants renewing certification starting January 2017.  
  • Most State Boards of Nursing require a minimum number of pharmacy contact hours to renew an advanced practice license.
Accreditation Council for Pharmacy Education
Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

To receive CE credit, the participant must read the monograph in its entirety, complete the online post-test and receive a score of 70% or greater, and complete the online evaluation.
Pharmacists and Pharmacy Technicians -
Be sure your profile has been updated with your NAPB e-profile # and birth date information BEFORE completing the online evaluation, or your credits cannot be reported to CPE Monitor.
Continuing pharmacy education credit is automatically reported to CPE Monitor once the post-test & evaluation are successfully completed.




  • Describe nicotine dependence and the symptoms of withdrawal from nicotine. List 3 medications that interact with tobacco smoke.
  • Be familiar with the components of "The 5 As" tobacco cessation counseling. Describe the advantages of smoking cessation quit lines.
  • Identify the generic name, brand name, and usual administration regimens of medications commonly used for smoking cessation.
  • Recognize a common or potentially serious side effect of nicotine replacement products, bupropion SR, and varenicline.


Karen Suchanek Hudmon, DrPH, MS, RPh
Professor of Pharmacy Practice at Purdue University, West Lafayette, Indiana and Professor of Clinical Pharmacy at the University of California, San Francisco., Purdue University

Brief Bio : Karen Hudmon,DrPH, MS, RPh, Professor of Pharmacy Practice Department of Pharmacy Practice, Purdue University College of Pharmacy. Specialties:public health pharmacy, cancer prevention research.

Lisa A. Kroon, PharmD
Chair of the Department of Clinical Pharmacy and Professor of Clinical Pharmacy at the University of California, San Francisco, School of Pharmacy; Co-Director of the Fontana Tobacco Treatment Center at UCSF Health. , UCSF

Brief Bio : Lisa A. Kroon, PharmD, Professor of Clinical Pharmacy, Department of Clinical Pharmacy, School of Pharmacy,University of california, San Francisco. Specialties: tobacco cessation, diabetes, community pharmacy practice.

Robin L. Corelli

Brief Bio : Robin L. Corelli, PharmD, Professor of Clinical Pharmacy, Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco. Specialties: tobacco cessation, community pharmacy practice.

Activity Number


Release Date: Nov 22, 2017
Credit Expiration Date: Nov 22, 2020

CE Hours